Gagan Singh Bedi

AstraZeneca India & Business Sweden launch ‘Unnati Healthcare 2.0 – Innovation Challenge’; nominations open till 10th December 2018

Unnati Healthcare 2.0 is a multi-partner initiative with a shared vision of encouraging innovative solutions that can impact the treatment…

6 years ago

AstraZeneca India launches once-daily Xigduo®XR tablets for comprehensive management of type 2 diabetes

Combines two powerful therapies (dapagliflozin and metformin hydrochloride extended-release) to offer comprehensive control of blood sugar with added advantage of…

7 years ago

Prebudget Expectation Attributed to Mr. Gagan Singh Bedi, MD, AstraZeneca Pharma India Limited.

New Delhi, January 31, 2018: The single most important recommendation from industry remains that of increasing healthcare spend as share…

7 years ago